Slide

NEWS & PRESS


Press Releases

September 5, 2023

CordenPharma Inaugurates Increased Peptide Production of Largest Worldwide SPPS Manufacturing Plant

6 September, 2023
Press Release > CordenPharma Inaugurates Increased Peptide Production of Largest Worldwide SPPS Manufacturing Plant
July 25, 2023

CordenPharma Establishes Technology & Science Advisory Board of Experts

July 26, 2023
Press Release > CordenPharma Establishes Technology & Science Advisory Board of Experts Across our 6 Platforms.
May 1, 2023

CordenPharma Announces Entry into Oligonucleotide API Manufacturing

May 2, 2023
Press Release > CordenPharma Announces Entry into Oligonucleotide Manufacturing at CordenPharma Colorado.
March 30, 2023

WACKER, CordenPharma, LMU & HU Berlin Train AI Machine-Learning Algorithm for Formulation of RNA Actives

March 30, 2023
Press Release > Wacker & CordenPharma Develop LNPs to Train AI Machine-Learning Algorithm for the Formulation of RNA Actives
January 9, 2023

CordenPharma Signs Multi-Year Agreement for the Manufacturing of a Commercial Peptide

10 January, 2023
Press Release > CordenPharma Signs Multi-Year Agreement for the Manufacturing of a Large-Volume Commercial Peptide
December 1, 2022

CordenPharma Joins the Science Based Targets initiative (SBTi)

December 2, 2022
Press Release > CordenPharma joins the Science Based Targets initiative (SBTi) to set greenhouse gas emission reduction targets.
June 1, 2022

Strategic Investment Increases xRNA-based LNP Formulation Services at Caponago Injectable Facility

June 1, 2022
Press Release > CordenPharma Invests in xRNA-based LNP Formulation Services at its Caponago Injectable Facility.
May 2, 2022

Astorg to Acquire Leading Pharmaceutical CDMO CordenPharma from ICIG

May 2, 2022
Press Release > Astorg to Acquire Leading Pharmaceutical CDMO CordenPharma from ICIG.
April 11, 2022

CordenPharma and WACKER To Produce mRNA Vaccines for Germany When Needed

April 11, 2022
Press Release > Wacker & CordenPharma win contract to be stand-by ready to produce mRNA vaccines for German government if needed.
March 1, 2022

CordenPharma Chenôve Increases Lipid Manufacturing Capacity to Support mRNA Vaccines

March 1, 2022
Press Release > CordenPharma Chenôve Increases Lipid Manufacturing Capacity to Support mRNA Vaccine Strategy.
January 26, 2022

CordenPharma Completes Acquisition of 3 Facilities from Vifor Pharma

February 1, 2022
Press Release > CordenPharma Completes Acquisition of 3 Facilities from Vifor Pharma
January 18, 2022

CordenPharma Collaborates on Continuous Peptide Manufacturing & Green Chemistry

January 18, 2022
Press Release > CordenPharma Collaborates with PeptiSystems on Green Continuous Peptide Manufacturing.
December 16, 2021

CordenPharma to Acquire Three Drug Product Manufacturing Facilities from Vifor Pharma

December 16, 2021
Press Release > CordenPharma to Acquire Three Drug Product Manufacturing Facilities from Vifor Pharma
December 14, 2021

WACKER and CordenPharma Develop Solutions for Formulating Lipid Nanoparticles

December 14, 2021
Press Release > Wacker & CordenPharma Develop Solutions for Formulating Lipid Nanoparticles, Expanding Their Portfolio for Advanced Medicines
December 1, 2021

CordenPharma Invests in Green Purification Technologies for Highly Pure Complex Lipids

December 2, 2021
Press Release > CordenPharma Invests in Green Purification Technologies for Highly Pure Complex Lipids